|By Marketwired .||
|July 29, 2014 07:10 AM EDT||
WATERLOO, ONTARIO -- (Marketwired) -- 07/29/14 -- Intellijoint Surgical Inc. (formerly, Avenir Medical), innovator in developing smart tools to improve joint replacement surgery, announced today that it has obtained clearance from the US Food and Drug Administration for its flagship product, Intellijoint HIP(TM).
"We're already approved in Canada, now we can begin marketing Intellijoint HIP(TM) to hospitals and orthopedic surgeons in the United States," said Armen Bakirtzian, CEO of Intellijoint(TM). "In the US, similar to Canada, our initial marketing plan is to work closely with certain leading surgeons and hospitals in specific geographic areas. In parallel, we are solidifying alliances with major implant companies while continuing to expand our product line."
"There are over a half million hip replacements a year in North America, and studies find that 30% of patients are dissatisfied with their surgery mainly due to avoidable leg length disparities, implant loosening and failures," said Dr. Wayne Paprosky, Professor and orthopedic surgeon at Rush Medical Center in Chicago, and member of Intellijoint(TM)'s Scientific Advisory Board. "We are very pleased to now be able to use Intellijoint HIP(TM) to enhance hip replacement surgery and benefit patients in the US."
Intellijoint HIP(TM) is a smart tool used to guide surgeons during hip replacement surgery. Its two miniature sensors are placed in the sterile field and communicate with a portable display. Controlled by the surgeon, it quantifies the measurements, often left to subjective judgment, required for selecting and positioning hip implants.
Adding only a few minutes to surgery, Intellijoint HIP(TM) assures surgeons and patients of obtaining the correct leg length and hip offset, which are the main sources of patient dissatisfaction in hip replacement. For hospitals, currently under pressure to use quality and efficiency metrics, it can help reduce costs and liabilities of implant failures and repeat surgeries that add over $1 billion a year to the US healthcare system.
About Intellijoint Surgical Inc.
Intellijoint(TM) is an early stage orthopedic medical device company committed to assist orthopedic surgeons specialized in joint arthroplasty to improve patient care. Focusing first on hip surgery, the Company develops and commercializes miniaturized, smart tools that enhance surgeon accuracy, increase hospital economic efficiencies, and improve patient outcomes.
Contact: CEO: Armen Bakirtzian
In his session at @DevOpsSummit at 19th Cloud Expo, Robert Doyle, lead architect at eCube Systems, will examine the issues and need for an agile infrastructure and show the advantages of capturing developer knowledge in an exportable file for migration into production. He will introduce the use of NXTmonitor, a next-generation DevOps tool that captures application environments, dependencies and start/stop procedures in a portable configuration file with an easy-to-use GUI. In addition to captur...
Jan. 20, 2017 12:45 AM EST Reads: 2,861
Who are you? How do you introduce yourself? Do you use a name, or do you greet a friend by the last four digits of his social security number? Assuming you don’t, why are we content to associate our identity with 10 random digits assigned by our phone company? Identity is an issue that affects everyone, but as individuals we don’t spend a lot of time thinking about it. In his session at @ThingsExpo, Ben Klang, Founder & President of Mojo Lingo, discussed the impact of technology on identity. Sho...
Jan. 20, 2017 12:45 AM EST Reads: 4,100
Fact is, enterprises have significant legacy voice infrastructure that’s costly to replace with pure IP solutions. How can we bring this analog infrastructure into our shiny new cloud applications? There are proven methods to bind both legacy voice applications and traditional PSTN audio into cloud-based applications and services at a carrier scale. Some of the most successful implementations leverage WebRTC, WebSockets, SIP and other open source technologies. In his session at @ThingsExpo, Da...
Jan. 20, 2017 12:45 AM EST Reads: 2,800
Jan. 20, 2017 12:00 AM EST Reads: 6,324
Jan. 19, 2017 11:45 PM EST Reads: 9,907
Jan. 19, 2017 09:45 PM EST Reads: 6,815
Jan. 19, 2017 09:45 PM EST Reads: 7,696
Jan. 19, 2017 09:00 PM EST Reads: 4,552
Jan. 19, 2017 08:45 PM EST Reads: 5,387
Jan. 19, 2017 07:30 PM EST Reads: 4,237
Jan. 19, 2017 05:30 PM EST Reads: 3,640
Jan. 19, 2017 05:15 PM EST Reads: 3,113
Jan. 19, 2017 05:15 PM EST Reads: 1,338
Jan. 19, 2017 04:45 PM EST Reads: 3,770
Jan. 19, 2017 04:45 PM EST Reads: 3,490